A New Era in TED: Navigating Choice, Sequencing, and Long-Term Care
This activity is supported by an educational grant from Viridian Therapeutics, Inc.

Already listened on another platform?
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Viridian Therapeutics, Inc.
Activity Description
The management of thyroid eye disease (TED) is entering a new era marked by the availability of multiple FDA-approved IGF-1R-targeted therapies and a growing pipeline of emerging treatment options. As the treatment landscape continues to evolve, clinicians require practical guidance to make informed, patient-centered therapeutic decisions across the disease continuum. Delivered in a dynamic Rapid-Fire Roundtable format, this activity will provide participants with expert insights into available therapies, highlighting key differences in clinical evidence, safety profiles, patient selection, retreatment strategies, and challenges to real-world implementation.
Target Audience
The intended audience for this activity is oculoplastic surgeons, ophthalmologists, and endocrinologists who are involved in the management of patients with thyroid eye disease (TED).
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Evaluate efficacy, safety, and practical implementation data for available and emerging IGF-1R-targeted therapies to support individualized treatment selection in TED.
- Apply evidence-based approaches for monitoring and managing adverse events associated with IGF-1R-targeted therapy.
- Develop individualized longitudinal treatment plans for patients with TED across the disease continuum.
Activity Chair
Kimberly Cockerham, MD, FACS
Oculoplastics and Orbital Disease
St Luke's at The Villages
The Villages, FL
Faculty
Jody G. Abrams, MD, FACS
Neuro-Ophthalmologist and Oculoplastic Surgeon
Sarasota Retina Institute
Sarasota, FL
Andrea Lora Kossler, MD, FACS
Associate Professor of Ophthalmology & Otolaryngology Head and Neck Surgery (Courtesy)
Director, Oculofacial Plastic & Orbital Surgery
Byers Eye Institute at Stanford University School of Medicine
Director, Multidisciplinary Thyroid Eye Disease Clinic
Vice President, Women in Ophthalmology
Palo Alto, CA
Planner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, November 20, 2026, to November 19, 2027.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 3 of the 4 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
In addition to providing a downloadable certificate, CME Providers accredited by the Accreditation Council for Continuing Medical Education (ACCME) have the ability to transmit CME credit data for all US physicians to an online repository, the ACCME Program and Activity Reporting System (PARS). CME credit data submitted to PARS can be viewed, managed, and tracked by US physicians in "CME Passport," a free, centralized web application. US Physicians who opt-in by providing their medical license number, state of licensure, and date of birth will have their credits automatically reported to the ACCME.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible companies. All relevant financial relationships with ineligible companies have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
Activity Chair and Faculty report the following relevant financial relationship(s)
Jody G. Abrams, MD, FACS
Consultant: Amgen, Viridian
Speaker Contracted by Ineligible Company: Amgen, Viridian
Independent Research Contractor: argenx, Viridian
Kimberly Cockerham, MD, FACS
Advisor: Genentech, Horizon/Amgen, Viridian
Consultant: Genentech, Horizon/Amgen, Viridian
Speaker Contracted by Ineligible Company: Viridian
Independent Research Contractor: argenx, Genentech/Roche, Horizon/Amgen, Immunovant, Tourmaline, Viridian
Andrea Lora Kossler, MD, FACS
Consultant: Amgen, Ethyreal Bio, Genentech, Immunovant, Kriya, Lassen, Viridian
Independent Research Contractor: Amgen, Kriya, Lassen, Sling, Viridian
Planner/Reviewer reports the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
AI Usage Disclosure Statement
Vindico Medical Education may use artificial intelligence (AI) tools to support the planning, development, review, evaluation, or administration of accredited continuing education activities. Any AI-assisted content or process is subject to human oversight, validation, and approval to ensure that the education remains accurate, evidence-based, balanced, independent, and free of commercial bias. When AI is used in a manner that materially affects learner-facing content or learner interaction, Vindico discloses that use and remains responsible for the integrity and quality of the accredited education.
Accessibility
Vindico Medical Education is committed to providing an inclusive learning environment and ensuring equitable access to our educational content. Our educational activities may include accessibility features, such as captioning, transcripts, reading aloud, and other platform-supported tools, to assist learners.
Participants who require additional accommodation, alternative formats, or assistance accessing content are encouraged to contact us at CME@VindicoCME.com. Vindico will make all reasonable efforts to provide alternative formats in a timely manner.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2026 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (eg, URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com